Skip to content

NTHI NTHI Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Merck & Co. logo
Merck & Co.MRK
20M0.0%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
10M

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's convertible preferred stock authorized shares?
NTHI (NTHI) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has NTHI's convertible preferred stock authorized shares changed year-over-year?
NTHI's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.